STRONGBRIDGE BIOPHARMA plc Finite-Lived Intangible Asset, Expected Amortization, Year Three
STRONGBRIDGE BIOPHARMA plc had Finite-Lived Intangible Asset, Expected Amortization, Year Three of $5.02 million as of 2020-12-31, per its 10-K filed 2021-03-03.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree · last filed 2021-03-03
- 2020-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Three $5.02M.
- 2019-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Three $5.02M.
- 2018-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Three $5.02M.
- 2017-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Three $5.02M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Three |
|---|---|
| 2020-12-31 | $5.02M 10-K · filed 2021-03-03 |
| 2019-12-31 | $5.02M 10-K · filed 2020-02-28 |
| 2018-12-31 | $5.02M 10-K · filed 2019-02-27 |
| 2017-12-31 | $5.02M 10-K · filed 2018-03-12 |